The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series

Abstract Introduction Infantile nephropathic cystinosis (INC) is an autosomal recessive lysosomal disorder in which patients develop deposits of cystine crystals in their kidneys and corneas from a young age. Methods We conducted a retrospective analysis of children with INC seen by ophthalmologists...

Full description

Bibliographic Details
Main Authors: Susmito Biswas, Krishanthy Sornalingam
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-12-01
Series:Ophthalmology and Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1007/s40123-018-0156-4
_version_ 1828474217547431936
author Susmito Biswas
Krishanthy Sornalingam
author_facet Susmito Biswas
Krishanthy Sornalingam
author_sort Susmito Biswas
collection DOAJ
description Abstract Introduction Infantile nephropathic cystinosis (INC) is an autosomal recessive lysosomal disorder in which patients develop deposits of cystine crystals in their kidneys and corneas from a young age. Methods We conducted a retrospective analysis of children with INC seen by ophthalmologists at the Manchester Royal Eye Hospital between 2002 and 2018, to evaluate clinical findings, symptoms and treatment. Results Twenty-two children diagnosed with INC from age 0 (prenatally) to 11 years were assessed. All evaluable patients had corneal cystine crystal deposits, and 15 had mild to moderate photophobia. Ten patients had other ocular conditions including blepharitis/chalzion (n = 6), swollen optic nerve (n = 3), punctate epitheliopathy (n = 3), corneal scarring (n = 1),and elevated intraocular pressure (n = 2). Confocal imaging identified nerve abnormalities in two patients (enlarged corneal nerve + abnormal-looking tortuous nerves in one patient and beaded nerves in the sub-basal plexus in the other), both of whom had significant crystal deposition in the anterior stroma. Visual acuity was relatively unaffected. All 22 patients were receiving oral cysteamine, and 21 were applying cysteamine eye drops (galenic preparation of 0.55% concentration, compounded by a hospital pharmacy). Recommended application frequency was at least eight times per day in all patients with dosing information available. Conclusions This case series of patients with INC highlights the consistent pattern of corneal cystine crystal deposition, which is universally present from a young age in this condition, and the high incidence of photophobia even in young children. Corneal manifestations of INC persisted despite frequent administration of the hospital pharmacy-made eye drop preparation. Reasons for this lack of efficacy may include the lag period between diagnosis and first prescription of cysteamine eye drops and the difficulty in maintaining rigorous compliance with this treatment. In addition, the challenge for patients of maintaining optimal storage conditions may adversely affect the stability and efficacy of cysteamine within this preparation. Funding Editorial assistance was funded by Orphan Europe Ltd.
first_indexed 2024-12-11T05:57:32Z
format Article
id doaj.art-8fe1673559014ee0b34aa8bff91c7a5f
institution Directory Open Access Journal
issn 2193-8245
2193-6528
language English
last_indexed 2024-12-11T05:57:32Z
publishDate 2018-12-01
publisher Adis, Springer Healthcare
record_format Article
series Ophthalmology and Therapy
spelling doaj.art-8fe1673559014ee0b34aa8bff91c7a5f2022-12-22T01:18:38ZengAdis, Springer HealthcareOphthalmology and Therapy2193-82452193-65282018-12-018112513610.1007/s40123-018-0156-4The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case SeriesSusmito Biswas0Krishanthy Sornalingam1Manchester Royal Eye Hospital, Manchester Academic Health Science CentreManchester Royal Eye Hospital, Manchester Academic Health Science CentreAbstract Introduction Infantile nephropathic cystinosis (INC) is an autosomal recessive lysosomal disorder in which patients develop deposits of cystine crystals in their kidneys and corneas from a young age. Methods We conducted a retrospective analysis of children with INC seen by ophthalmologists at the Manchester Royal Eye Hospital between 2002 and 2018, to evaluate clinical findings, symptoms and treatment. Results Twenty-two children diagnosed with INC from age 0 (prenatally) to 11 years were assessed. All evaluable patients had corneal cystine crystal deposits, and 15 had mild to moderate photophobia. Ten patients had other ocular conditions including blepharitis/chalzion (n = 6), swollen optic nerve (n = 3), punctate epitheliopathy (n = 3), corneal scarring (n = 1),and elevated intraocular pressure (n = 2). Confocal imaging identified nerve abnormalities in two patients (enlarged corneal nerve + abnormal-looking tortuous nerves in one patient and beaded nerves in the sub-basal plexus in the other), both of whom had significant crystal deposition in the anterior stroma. Visual acuity was relatively unaffected. All 22 patients were receiving oral cysteamine, and 21 were applying cysteamine eye drops (galenic preparation of 0.55% concentration, compounded by a hospital pharmacy). Recommended application frequency was at least eight times per day in all patients with dosing information available. Conclusions This case series of patients with INC highlights the consistent pattern of corneal cystine crystal deposition, which is universally present from a young age in this condition, and the high incidence of photophobia even in young children. Corneal manifestations of INC persisted despite frequent administration of the hospital pharmacy-made eye drop preparation. Reasons for this lack of efficacy may include the lag period between diagnosis and first prescription of cysteamine eye drops and the difficulty in maintaining rigorous compliance with this treatment. In addition, the challenge for patients of maintaining optimal storage conditions may adversely affect the stability and efficacy of cysteamine within this preparation. Funding Editorial assistance was funded by Orphan Europe Ltd.http://link.springer.com/article/10.1007/s40123-018-0156-4Cysteamine eye dropsNephropathic cystinosisPhotophobia
spellingShingle Susmito Biswas
Krishanthy Sornalingam
The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
Ophthalmology and Therapy
Cysteamine eye drops
Nephropathic cystinosis
Photophobia
title The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
title_full The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
title_fullStr The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
title_full_unstemmed The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
title_short The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
title_sort ocular status of cystinosis patients receiving a hospital pharmacy made preparation of cysteamine eye drops a case series
topic Cysteamine eye drops
Nephropathic cystinosis
Photophobia
url http://link.springer.com/article/10.1007/s40123-018-0156-4
work_keys_str_mv AT susmitobiswas theocularstatusofcystinosispatientsreceivingahospitalpharmacymadepreparationofcysteamineeyedropsacaseseries
AT krishanthysornalingam theocularstatusofcystinosispatientsreceivingahospitalpharmacymadepreparationofcysteamineeyedropsacaseseries
AT susmitobiswas ocularstatusofcystinosispatientsreceivingahospitalpharmacymadepreparationofcysteamineeyedropsacaseseries
AT krishanthysornalingam ocularstatusofcystinosispatientsreceivingahospitalpharmacymadepreparationofcysteamineeyedropsacaseseries